首页> 外文期刊>American Journal of Translational Research >Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis
【24h】

Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis

机译:奥米加南对腹膜炎大鼠结肠吻合口愈合的影响

获取原文
           

摘要

Background: This study investigates the effects of the antimicrobial cationic peptide omiganan-alone and combined with the antibiotic imipenem-on colonic anastomosis healing in presence of intraperitoneal sepsis induced in a rodent model of cecal ligation and puncture (CLP). Methods: Forty male Wistar rats were divided into 5 groups of 8 animals. Group 1 (control group) underwent laparotomy and cecal mobilization and the next day received left colon anastomosis. In group 2 (CLP without treatment), group 3 (CLP + imipenem), group 4 (CLP + omiganan), and group 5 (CLP + omiganan + imipenem), the left colon anastomosis was performed the day after CLP. Imipenem and omiganan were administered by intraperitoneal injection immediately before anastomosis construction and subsequently at 24 h intervals until the 7th postoperative day, when rats were sacrificed. Anastomotic bursting pressure was measured in situ. Tissue samples were collected for determination of hydroxyproline content and histological characteristics. Results: Only rats receiving omiganan + imipenem displayed re-epithelialization, reduced neovascularization of granulation tissue, and a bursting pressure that was similar to that of controls. Omiganan-alone and combined with imipenem-was associated with a better control of inflammatory parameters than imipenem alone. In addition omiganan, like imipenem, counteracted the collagen depletion typical of sepsis. Conclusions: This experimental study demonstrates the efficacy of the new antimicrobial agent omiganan, alone and in combination with imipenem, in delaying the effects of intraperitoneal sepsis on colonic anastomosis healing and provides evidence of the value of omiganan as a therapeutic agent.
机译:背景:这项研究调查了在盲肠结扎和穿刺(CLP)啮齿动物模型诱导的腹膜内败血症的情况下,单独使用抗微生物阳离子肽omiganan联合抗生素亚胺培南对结肠吻合的愈合作用。方法:将40只雄性Wistar大鼠分成5组,每组8只。第一组(对照组)进行剖腹手术和盲肠动员,第二天接受左结肠吻合术。在第2组(未经治疗的CLP),第3组(CLP +亚胺培南),第4组(CLP +亚米加南)和第5组(CLP +亚米加南+亚胺培南),在CLP后第二天进行左结肠吻合术。在吻合术即将进行之前,腹膜内注射亚胺培南和奥米加南,随后每隔24小时间隔一次,直到术后第7天,将大鼠处死。原位测量吻合口破裂压力。收集组织样品以测定羟脯氨酸含量和组织学特征。结果:只有接受含gan虫+亚胺培南的大鼠表现出上皮再形成,肉芽组织新生血管减少和爆发压力与对照组相似。与单独使用亚胺培南相比,单独使用Omiganan并与亚胺培南联合使用可更好地控制炎症参数。此外,奥米加南(如亚胺培南)可抵消败血症典型的胶原蛋白消耗。结论:这项实验研究证明了新型抗微生物剂奥米加南单独使用或与亚胺培南联用可有效延缓腹膜内脓毒症对结肠吻合愈合的作用,并提供了奥米加南作为治疗剂的价值的证据。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号